In June, the U.S. Supreme Court is expected to weaken or topple its nearly 50-year-old abortion rights decision, Roe v. Wade, giving states wide latitude to restrict the procedure.
But most legislatures will be adjourned by then, and anti-abortion lawmakers aren’t waiting to address what they expect will be one result of widespread limits on clinical abortions: spiraling demand for medication abortions.
Since January, legislators in at least 20 states have proposed bills that would restrict or ban access to abortion pills approved more than two decades ago by the U.S. Food and Drug Administration.
